Among patients with MSP and PsA, lifetime expenditures decreased with advanced age, but healthcare cost per life-year showed an increasing trend along with increasing age for both male and female patients ( Tables 1 and 2 ).
← all excerpts
Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017.
1
—
—